FDA expands Tecentriq approval for metastatic lung cancer
1 month ago - By Healio
The FDA expanded the approval of atezolizumab to include first-line monotherapy of patients with metastatic non-small cell lung cancer whose tumors have high PD-L1 expression.
The approval applies to use of the atezolizumab by patients who have no EGFR or anaplastic lymphoma kinase genomic tumor aberrations.
This is the fourth indication in metastatic NSCLC and fifth overall in lung cancer for atezolizumab, a monoclonal antibody designed to bind with PD-L1.
“We are pleased to offer people with certain types of lung cancer a new chemotherapy-free option that can
Read more ...
The headlines of Master Doctor
Will a Covid mask starve your brain of oxygen?
A study found that face coverings reduce the risk of coronavirus transmission by a third, though some people on the internet fear using protection will cause them brain damage.
Fat Cell Hormone can Boost Potential of Stem Cell Therapy
Adiponectin, a hormone derived from fat cells, improves mesenchymal stem cell-based treatment of heart failure, finds a new study.
Another coronavirus death recorded in Wales and seven new cases
The latest Public Health Wales figures were revealed as holiday businesses in Wales started to re-open
Excess Deaths from COVID-19; Getting to Herd Immunity: It's TTHealthWatch!
TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine, and Rick Lange, MD, president of the Texas...
Family Planning During COVID-19
World population day: It's time to bring back the 'choice, voice debate' on family planning during coronavirus pandemic.
On a keto diet? Satisfy that sweet tooth with these keto-approved sweeteners
The keto diet may seem daunting to anyone who loves carbs and sweets. After all, dieting means being careful about what you eat. However, there are many ways to make dishes...
IMedicalApps: COVID-19 Protocols
Recently, Brigham and Women's Hospital released a comprehensive app of all of its COVID-19 clinical guidelines, called COVID Protocols, which are also available online. This...
Novel Drug Candidate may Develop Effective Treatments for Brain Disorders
Novel chemical compound discovered has the potential to become a new drug for the treatment of core symptoms of brain disorders such as Down syndrome and autism, reports a new...
Why Lopinavir and Hydroxychloroquine are Ineffective Against COVID-19
Lopinavir and Hydroxychloroquine do not work on COVID-19 because the concentration of both these drugs in the lungs of patients are not sufficient to fight the infection...
COVID-19 Infection can be Transmitted in the Womb, Study
Intrauterine transmission of COVID-19 infection from mother to baby can be confirmed based on immunohistochemical and ultrastructural evidence of SARS-CoV-2 nucleocapsid...